Phase II clinical trial of diaziquone in the treatment of patients with epithelial ovarian cancer: a Gynecologic Oncology Group Study.
作者信息
Slayton R E, Blessing J A, Sutton G P, Homesley H D, Park R
出版信息
Cancer Treat Rep. 1986 Feb;70(2):309-10.
PMID:3948196
Abstract
摘要
相似文献
1
2
3
4
5
Phase II clinical trial of diaziquone in bronchogenic carcinoma.
Cancer Treat Rep. 1985 Jul-Aug;69(7-8):921-2.
6
Phase II trial of diaziquone in advanced upper aerodigestive cancer.地吖醌用于晚期上消化道癌症的II期试验。
Cancer Treat Rep. 1985 Jan;69(1):141.
7
Phase II trial of diaziquone in malignant mesothelioma.二氮喹酮用于恶性间皮瘤的II期试验。
Cancer Treat Rep. 1986 Mar;70(3):429.
8
Phase II study of diaziquone in advanced soft tissue and bony sarcoma: a Southwest Oncology Group study.重氮醌用于晚期软组织和骨肉瘤的II期研究：一项西南肿瘤协作组的研究
Cancer Treat Rep. 1985 Sep;69(9):1035-6.
9
Phase II trial of diaziquone in advanced renal adenocarcinoma.
Cancer Treat Rep. 1984 Jul-Aug;68(7-8):1055-6.
10
Phase II study of diaziquone in patients with advanced carcinoma of the lung.重氮醌用于晚期肺癌患者的II期研究。
Cancer Treat Rep. 1984 Sep;68(9):1193-4.
引用本文的文献
1
A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix. A Gynecologic Oncology Group study.氮芥醌（AZQ）治疗复发性子宫颈腺癌和腺鳞癌患者的II期临床试验。一项妇科肿瘤学组的研究。
Invest New Drugs. 1989 Nov;7(4):337-40. doi: 10.1007/BF00173764.
Zotero 插件